GlaxoSmithKline PLC (ADR) (GSK) Teams Up With Fimbrion Therapeutics, Inc.
GlaxoSmithKline plc (ADR) (NYSE:GSK) (GSK) has recently entered into a collaborative agreement with Fimbrion Therapeutics, Inc.
Glaxosmithkline Plc (GSK)
Market is closed
News
- First
- << Previous
- 131 - 140
- Next >>
GlaxoSmithKline Plc (GSK) Shrugs Skeptics Concerns To Launch Cold Flu Tracker App
GlaxoSmithKline Plc (NYSE:GSK) is forging forward with its cold and flu tracker app even on coming under criticism from skeptics who continue to question the motive behind its unveiling.
Medecins Sans Frontieres Happy with GlaxoSmithKline PLC (ADR) (GSK) Price Reduction For Synflorix
Numerous complaints by medical charity Medecins Sans Frontieres over the cost of pneumococcal vaccine given to refugees by GlaxoSmithKline PLC (ADR) (NYSE:GSK) have yielded fruit.
Inside the FDA Ebola Edition: Frontrunners Merck & Co., Inc. (MRK), GlaxoSmithKline PLC (ADR) (GSK)
Back on May 12, 2015, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee released a briefing document detailing the process for licensure of Ebola vaccines...
Why Are These Five Stocks on Investors' Radars Today?
Markets are struggling to find a direction on Monday amid the Institute for Supply Management data that showed that its index of national factory activity amounted to 52.6 in June, missing the consensus...
Why GlaxoSmithKline, Groupon, Lending Club And 2 Micro-Caps Are Trending Today
The U.S stock markets are trading up on Monday even as oil has tumbled, thanks to strong financial results and M&A news. Among the stocks on the move today are LendingClub Corp (NYSE:LC), Ballard Power...
With Brexit Looming, Hedge Funds Weigh In On British Stocks
The Brexit is looming and, no matter how cute a name we can come up with, the issue is as serious as can be.
GlaxoSmithKline PLC (ADR) (GSK) To Accelerate Filing For COPD Combo Treatment
GlaxoSmithKline plc (ADR) (NYSE:GSK) has come up with a plan that will enable it to file for approval of its triple-combo drug for COPD patients sooner than earlier anticipated.
Johnson & Johnson (JNJ) And GlaxoSmithKline PLC (ADR) (GSK) Rheumatoid Arthritis Drug Meets Targets In Large Phase 3 Study
A drug being developed jointly by Johnson & Johnson (NYSE:JNJ) and GlaxoSmithKline plc (ADR) (NYSE:GSK) met endpoints in a large Phase 3 study that enrolled 1,670 patients.
- First
- << Previous
- 131 - 140
- Next >>
Billionaire Hedge Funds
